Literature DB >> 33784014

Single-cell transcriptomics provides new insights into the role of fibroblasts during peritoneal fibrosis.

Jinhua Zhang1, Yuxian Chen2, Tufeng Chen3, Bin Miao1, Zuofu Tang1, Xiao Hu1, You Luo1, Tong Zheng1, Ning Na1.   

Abstract

BACKGROUND: The contributions of various types of cell populations in dialysis-related peritoneal fibrosis are poorly understood. Single-cell RNA sequencing brings single-cell level resolution to the analysis of cellular transcriptomics, which provides a new way to further characterize the distinct roles and functional states of each cell population during peritoneal fibrosis.
METHODS: Single-cell transcriptomics from normal peritoneal tissues of six patients, from effluent of patients with short-term peritoneal dialysis (less than 2 weeks, n = 6), and from long-term peritoneal dialysis patients (more than 6 years, n = 4) were analyzed.
RESULTS: We identified a distinct cell component between samples among different groups. Functional analysis of the differentially expressed genes identified cell type specific biological processes relevant to different fibrosis stages. Well-known key molecular mechanisms participating in the pathophysiology of peritoneal fibrosis were vitrified, and some of them were found to be restricted to specific cell types. Gradually growing enrichment of PI3K/AKT/mTOR pathway and impairment of oxidative phosphorylation in mesothelial cells and fibroblasts were found from healthy control, short-term dialysis, to long-term dialysis, respectively. The fibroblasts' population obtained from the patients, who received peritoneal dialysis, showed a functional characteristic of immune-chemotaxis and immune response, which was characterized by broadly significant increase in the expression of interleukins, chemokines, cytokines, and human leukocyte antigens. Furthermore, we described the intercellular crosstalk networks based on receptor-ligand interactions, and highlighted a central role of fibroblasts in regulating the key mechanisms of peritoneal fibrosis through crosstalk with other cells.
CONCLUSIONS: In summary, despite describing information for fibrogenic molecular mechanisms in the resolution level of individual cell populations, this work identifies the significant functional evolution of fibroblasts during peritoneal fibrosis. This study also reveals the intercellular receptor-ligand interactions in which the fibroblasts serve as a major node, eventually providing new insights into the role of fibroblasts during disease pathogenesis.
© 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

Entities:  

Keywords:  fibroblasts; peritoneal fibrosis; receptor-ligand interactions; single-cell transcriptomics

Mesh:

Year:  2021        PMID: 33784014      PMCID: PMC7908046          DOI: 10.1002/ctm2.321

Source DB:  PubMed          Journal:  Clin Transl Med        ISSN: 2001-1326


  32 in total

1.  Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.

Authors:  María Yáñez-Mó; Enrique Lara-Pezzi; Rafael Selgas; Marta Ramírez-Huesca; Carmen Domínguez-Jiménez; José A Jiménez-Heffernan; Abelardo Aguilera; José A Sánchez-Tomero; M Auxiliadora Bajo; Vincente Alvarez; M Angeles Castro; Gloria del Peso; Antonio Cirujeda; Carlos Gamallo; Francisco Sánchez-Madrid; Manuel López-Cabrera
Journal:  N Engl J Med       Date:  2003-01-30       Impact factor: 91.245

2.  Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.

Authors:  An S De Vriese; Ronald G Tilton; Siska Mortier; Norbert H Lameire
Journal:  Nephrol Dial Transplant       Date:  2006-06-06       Impact factor: 5.992

Review 3.  Understanding fibroblast heterogeneity in the skin.

Authors:  Ryan R Driskell; Fiona M Watt
Journal:  Trends Cell Biol       Date:  2014-11-07       Impact factor: 20.808

Review 4.  Protective transcriptional mechanisms in cardiomyocytes and cardiac fibroblasts.

Authors:  Cameron S Brand; Janet K Lighthouse; Michael A Trembley
Journal:  J Mol Cell Cardiol       Date:  2019-04-28       Impact factor: 5.000

Review 5.  Properties and Immune Function of Cardiac Fibroblasts.

Authors:  Milena B Furtado; Muneer Hasham
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 6.  Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis.

Authors:  Gilberto Baroni; Adriana Schuinski; Thyago P de Moraes; Fernando Meyer; Roberto Pecoits-Filho
Journal:  Mediators Inflamm       Date:  2012-03-25       Impact factor: 4.711

7.  Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis.

Authors:  Meijun Si; Qianqian Wang; Yin Li; Hongchun Lin; Dan Luo; Wenbo Zhao; Xianrui Dou; Jun Liu; Hui Zhang; Yong Huang; Tanqi Lou; Zhaoyong Hu; Hui Peng
Journal:  Sci Transl Med       Date:  2019-06-05       Impact factor: 19.319

8.  Anatomic demarcation by positional variation in fibroblast gene expression programs.

Authors:  John L Rinn; Chanda Bondre; Hayes B Gladstone; Patrick O Brown; Howard Y Chang
Journal:  PLoS Genet       Date:  2006-07       Impact factor: 5.917

9.  Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways.

Authors:  Evan Der; Hemant Suryawanshi; Pavel Morozov; Manjunath Kustagi; Beatrice Goilav; Saritha Ranabothu; Peter Izmirly; Robert Clancy; H Michael Belmont; Mordecai Koenigsberg; Michele Mokrzycki; Helen Rominieki; Jay A Graham; Juan P Rocca; Nicole Bornkamp; Nicole Jordan; Emma Schulte; Ming Wu; James Pullman; Kamil Slowikowski; Soumya Raychaudhuri; Joel Guthridge; Judith James; Jill Buyon; Thomas Tuschl; Chaim Putterman
Journal:  Nat Immunol       Date:  2019-05-20       Impact factor: 25.606

Review 10.  Targeting CCL5 in inflammation.

Authors:  Rafael Elias Marques; Rodrigo Guabiraba; Remo Castro Russo; Mauro Martins Teixeira
Journal:  Expert Opin Ther Targets       Date:  2013-10-03       Impact factor: 6.902

View more
  1 in total

1.  Macrophages in Renal Injury, Repair, Fibrosis Following Acute Kidney Injury and Targeted Therapy.

Authors:  Hui Chen; Na Liu; Shougang Zhuang
Journal:  Front Immunol       Date:  2022-07-13       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.